BIT Capital GmbH
- SEC CIK
- 0002053305
- Latest filing
- Aug 12, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by BIT Capital GmbH, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −26,237−100.0% | Sold out | Holders |
| Q3 2024 | 26,237 | $1.52M | 0.1% | +3,499+15.4% | Added | Holders |
| Q2 2024 | 22,738 | $1.04M | 0.1% | +10,795+90.4% | Added | Holders |
| Q1 2024 | 11,943 | $790.6K | 0.1% | +1,512+14.5% | Added | Holders |
| Q4 2023 | 10,431 | $414.7K | <0.1% | +3,469+49.8% | Added | Holders |
| Q3 2023 | 6,962 | $221.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 6,962 | $279.7K | <0.1% | +6,962 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −1,330−100.0% | Sold out | Holders |
| Q4 2022 | 1,330 | $63.9K | <0.1% | +1,330 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −1,700−100.0% | Sold out | Holders |
| Q1 2022 | 1,700 | $92.4K | <0.1% | +1,700 | New | Holders |